A modified recombinant factor VIIa: can we make it work harder, better, faster, stronger?
Levy
J H
JH
Department of Anesthesiology, Emory University Hospital, Atlanta, GA, USA. jlevy01@emory.edu
Levi
M
M
D000818:Animals; D015942:Factor VIIa / Q000737:chemistry / Q000627:therapeutic use*; D015316:Genetic Therapy / Q000379:methods; D006467:Hemophilia A / Q000628:therapy; D006470:Hemorrhage; D006487:Hemostasis; D006801:Humans; D011994:Recombinant Proteins / Q000737:chemistry / Q000627:therapeutic use; D013917:Thrombin / Q000378:metabolism
D011994:Recombinant Proteins; C103587:recombinant FVIIa; D015942:Factor VIIa; D013917:Thrombin